The UGT1A1 gene is responsible for the metabolism of SN-38, which is an active metabolite of irinotecan, and variants of UGT1A1 have been reported to intensify myelosuppression, such as severe neutropenia [6]. This evidence concerns the gene UGT1A1 and neutropenia.